Form 4 for PCVX Vaxcyte, Inc.
Accepted 2021-12-30 00:00:00 ET · period of report 2021-12-29 · accession 0001209191-21-071604 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-30 | 2021-12-29 | PCVX | Sauer Paul | SVP Process Dev, Manufacturing | S - Sale | $25.00 | -6,000 | 27.1K | -18% | -$150.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-29 | S | D | 6,000 | $25.00 | 27,125 | D | — | — |